Our clinical updates provide you with timely information about Memorial Sloan Kettering’s new treatment approaches, key clinical trials, and innovations in detecting and treating many cancers.

135 Clinical Updates found

Clinical Update

Active Surveillance of Prostate Cancer: Advances for More-Accurate Risk Assessment

Active surveillance of prostate cancer is being increasingly utilized for men with low-risk cancer. But some men with potentially life-threatening cancers are being inadvertently enrolled in such programs, driving the need for more accurate decision-making tools such as the 4Kscore test developed at Memorial Sloan Kettering.

  • Thursday, October 12, 2017

Clinical Update

Data Proves a Significant Survival Advantage with Hepatic Arterial Infusion in Metastatic Colorectal Cancer

Hepatic arterial infusion chemotherapy given to colorectal cancer patients with liver metastases extends their survival by almost two years, according to a large retrospective study from Memorial Sloan Kettering recently published in the JCO.

  • Thursday, October 12, 2017

Clinical Update

Active Monitoring of Papillary Thyroid Cancer

American Thyroid Association guidelines endorse close observation as a treatment option for many small papillary thyroid tumors rather than surgery. MSK endocrinologist Michael Tuttle MD discusses why monitoring such cancers is a viable approach.

  • Thursday, August 31, 2017

Clinical Update

Talking with Young Cancer Patients about their Fertility Options

In 2009, Memorial Sloan Kettering established the nurse-led Cancer and Fertility Program to overcome barriers to getting information and provide resources to help clinicians have discussions about fertility options with their patients.

  • Thursday, August 24, 2017

Clinical Update

Expanding Strategies for Breast Cancer Prevention in a High Risk Population

Data from a recent study on women enrolled in Memorial Sloan Kettering Cancer Center’s high-risk breast cancer surveillance program highlights that a “substantial number” would benefit from interventions to mitigate modifiable risk.

  • Wednesday, August 23, 2017

Clinical Update

Simple liquid biopsy enables targeted therapies in castration-resistant prostate cancer

Despite the recent development of novel hormonal therapies - such as enzalutamide and abiraterone - directed at the androgen receptor in the management of castration-resistant prostate cancer, a proportion of men have disease that progresses on these drugs.

  • Monday, June 5, 2017

Clinical Update

A Sharp Advantage for Men with Prostate Cancer

An innovative technique called stereotactic hypofractionated accelerated radiation to the prostate – aka SHARP - safely and effectively delivers powerful doses of radiation directly to the patient’s tumor with incredible precision.

  • Friday, June 2, 2017

Clinical Update

Memorial Sloan Kettering Physician-Scientist Leads Global Genome Sequencing Collaboration

AACR Project GENIE steering committee head and Chair of MSK’s Human Oncology and Pathogenesis Program, Dr. Charles Sawyers, discusses how the first batch of genomic sequencing data fulfills an unmet need in oncology.

  • Wednesday, February 15, 2017

Clinical Update

Novel Approach Reduces Treatment Toxicities in Patients with HPV-Related Oropharynx Cancer

The incidence of mouth and throat cancer is on the rise due to oral transmission of the human papilloma virus, but the "silver lining" of this phenomenon is doctors at Memorial Sloan Kettering have significantly reduced the intensity of treatment while achieving excellent outcomes for these patients.

  • Wednesday, February 15, 2017

Clinical Update

Overcoming Barriers to Maintaining Physical Activity during Cancer Care

Despite the proven benefits of exercise, even while receiving cancer treatment, new research undertaken by Memorial Sloan Kettering’s Integrative Medicine Service, shows that the majority of cancer patients report significant decreases in their physical activity levels after their cancer diagnosis.

  • Wednesday, February 15, 2017